# Circular bioeconomy-driven carotenoid production by Agrococcus sp. NP24 using cheese whey byproduct: process optimization and bioactivity assessment

**Authors:** Nehad Noby, Fatma Elsayed, Mahmoud M. Agami, Nadia A. Soliman

PMC · DOI: 10.3389/fmicb.2025.1747717 · Frontiers in Microbiology · 2026-02-03

## TL;DR

A new method uses cheese whey to produce carotenoids with Agrococcus sp. NP24, showing good stability and bioactivity for food coloring.

## Contribution

Optimized production of zeaxanthin monoester from cheese whey using Agrococcus sp. NP24 with bioactivity evaluation.

## Key findings

- Maximum pigment yield of 0.0567 mg/mL achieved using 80% whey and optimized nutrients.
- Pigment showed potent antioxidant activity (IC₅₀ of 6 μg/mL) and cytotoxicity against cancer cells.
- Pigment was stable up to 50°C but lost 74% activity after 1 hour of daylight exposure.

## Abstract

Growing interest in the circular economy has promoted the use of agri-food wastes as fermentable and readily available substrates for microbial cultivation, offering a sustainable and cost-effective strategy for natural pigment production. In this study, cheese whey was utilized as a nutritional substrate for pigment synthesis by an isolated strain identified as Agrococcus sp. NP24 (PQ097720.1). The work further aimed to characterize the produced pigment and evaluate its bioactivity. The culture medium was optimized using a Box–Behnken design (BBD). The carotenoid profile of the extracted pigment was analyzed by HPLC-DAD and LC–MS. Pigment stability was assessed across a range of pH values and temperatures, and its antimicrobial, antioxidant, and anticancer activities were examined. The pigment was identified as zeaxanthin monoester (C14:0). The maximum pigment yield (0.0567 mg/mL extract) was achieved after 72 h at 20 °C using a medium containing 80% whey (v/v), 0.5% peptone (w/v), 0.97 g % casein (w/v), and supplemented with 0.5% (w/v) yeast extract and 0.5% (w/v) MgSO₄. The pigment remained fully stable up to 50 °C. Acidic conditions (pH 3–5) enhanced pigment absorbance compared to neutral and alkaline pHs. In contrast, exposure to daylight markedly reduced pigment stability, leaving only 26% residual activity after 1 h. The pigment exhibited potent antioxidant activity with an IC₅₀ of 6 μg/mL. It also showed cytotoxic and significant selectivity against the triple-negative breast cancer cell line MDA-MB-231 and the colorectal carcinoma cell line HCT-116, with IC₅₀ values of 3.3 mg/mL and 0.56 mg/mL, respectively, while no cytotoxicity was observed toward the HepG-2 hepatoblastoma cell line. The carotenoid did not display significant antimicrobial activity. In conclusion, the cost-effective production of NP24 carotenoids, combined with their favorable stability and bioactivity, supports their potential use as natural colorants in food applications.

## Linked entities

- **Chemicals:** doxorubicin (PubChem CID 31703)
- **Diseases:** breast cancer (MONDO:0004989), colorectal carcinoma (MONDO:0024331), hepatoblastoma (MONDO:0018666)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** IGKV5-2 (immunoglobulin kappa variable 5-2) [NCBI Gene 28907] {aka B2, IGKV52}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, NPM1 (nucleophosmin 1) [NCBI Gene 4869] {aka B23, NPM}, TAGLN3 (transgelin 3) [NCBI Gene 29114] {aka NP22, NP24, NP25}, GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}
- **Diseases:** neuroblastoma (MESH:D009447), osteosarcoma (MESH:D012516), inflammatory (MESH:D007249), hepatoblastoma (MESH:D018197), cancer (MESH:D009369), breast adenocarcinoma (MESH:D001943), TNBC (MESH:D064726), hepatocellular carcinoma (MESH:D006528), carcinogenic (MESH:D011230), Colorectal carcinoma (MESH:D015179), cytotoxicity (MESH:D064420)
- **Chemicals:** alkenes (MESH:D000475), staphyloxanthin (MESH:C031841), Carotenoid (MESH:D002338), free radical (MESH:D005609), fucoxanthin (MESH:C025164), ethanol (MESH:D000431), NaOH (MESH:D012972), Formic acid (MESH:C030544), zeaxanthin (MESH:D065146), phosphate (MESH:D010710), oxygen (MESH:D010100), formazan (MESH:D005562), deinoxanthin (MESH:C547822), Methanol (MESH:D000432), NaCl (MESH:D012965), ester (MESH:D004952), 2,2-Diphenyl-1-picrylhydrazyl (MESH:C004931), Acetonitrile (MESH:C032159), agar (MESH:D000362), flavins (MESH:D005415), carbon (MESH:D002244), lactose (MESH:D007785), nitrogen (MESH:D009584), hydroxide (MESH:C031356), melanin (MESH:D008543), bacterioruberin (MESH:C002951), monascin (MESH:C517880), polyene (MESH:D011090), CO2 (MESH:D002245), L-glutamine (MESH:D005973), glucose (MESH:D005947), DMSO (MESH:D004121), anthraquinone (MESH:D000880), acetate (MESH:D000085), KCl (MESH:D011189), xanthophyll (MESH:D024341), glycerol (MESH:D005990), violaxanthin (MESH:C005613), Carotenoid extract (-), geranyl-geranyl diphosphate (MESH:C002963), lutein (MESH:D014975), hydrocarbon (MESH:D006838), fatty acid (MESH:D005227), carbohydrates (MESH:D002241), MgSO4 (MESH:D008278), MTT (MESH:C070243)
- **Species:** Deinococcus radiodurans (species) [taxon 1299], Escherichia coli (E. coli, species) [taxon 562], Agrococcus jenensis (species) [taxon 46353], Leifsonia shinshuensis (species) [taxon 150026], Candida albicans (species) [taxon 5476], Agrococcus sp. (species) [taxon 1872417], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090], Agrococcus lahaulensis (species) [taxon 341722], PX clade (clade) [taxon 569578], Streptomyces (genus) [taxon 1883], Deinococcus sp. (species) [taxon 47478], Agrococcus pavilionensis RW1 (strain) [taxon 1330458], Arthrobacter sp. (species) [taxon 1667], uncultured actinomycete (species) [taxon 100235], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280]
- **Cell lines:** CVCL_0291 — Homo sapiens (Human), Transformed cell line (CVCL_8V88), HCT-116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), ATCC 25922 — Homo sapiens (Human), Finite cell line (CVCL_LK64), HepG-2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), CVCL0062 — Homo sapiens (Human), Arrhythmogenic right ventricular dysplasia, Induced pluripotent stem cell (CVCL_C6Q1), HTB-26 — Mus musculus (Mouse), Hybridoma (CVCL_A8FQ), KYSE30 — Homo sapiens (Human), Esophageal squamous cell carcinoma, Cancer cell line (CVCL_1351), PC - 3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), HB-8065 — Homo sapiens (Human), Conditionally immortalized cell line (CVCL_J982), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), Saos-2 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0548), UDEC-P1 — Mus musculus (Mouse), Carcinoma of the mouse prostate gland, Cancer cell line (CVCL_VQ82), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), Neuro-2a — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12910483/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12910483/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12910483/full.md

---
Source: https://tomesphere.com/paper/PMC12910483